Product Name：

Eltrombopag olamine

Synonyms:

Promacta; Revolade; SB 497115GR; Unii-4U07F515lg 3'-[(2Z)-2-[1-(3,4-Dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene] hydrazinyl]-2'- hydroxy-[1,1'-biphenyl]-3-carboxylic acid compd. with 2-aminoethanol

Description:

Red to brown powder

Cas No.：

496775-62-3

Molecular Formula：

C25H22N4O4.2(C2H7NO)

Molecular Weight：

564.64

Purity：

99%min HPLC

Quality Standard:

Enterprise standard

Usage：

1. Eltrombopag olamine is indicated for the treatment of thrombocytopenia in patients with chronic immune (idiopathic) thrombocytopenia (ITP) who have had an insufficient response to corticosteroids, immunoglobulins, or splenectomy.
2. Eltrombopag olamine is indicated for the treatment of thrombocytopenia in patients with chronic hepatitis C to allow the initiation and maintenance of interferon-based therapy.
3. Eltrombopag olamine is indicated for the treatment of patients with severe aplastic anemia who have had an insufficient response to immunosuppressive therapy.